Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.
作者信息
Auböck J, Fritsch P
出版信息
Br Med J (Clin Res Ed). 1985 Jun 29;290(6486):1969-70. doi: 10.1136/bmj.290.6486.1969.
Abstract
摘要
相似文献
1
Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.无症状性高尿酸血症与别嘌醇诱发的中毒性表皮坏死松解症。
Br Med J (Clin Res Ed). 1985 Jun 29;290(6486):1969-70. doi: 10.1136/bmj.290.6486.1969.
2
Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis.无症状性高尿酸血症与别嘌醇诱发的中毒性表皮坏死松解症。
Br Med J (Clin Res Ed). 1985 Aug 17;291(6493):485. doi: 10.1136/bmj.291.6493.485.
3
Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?具有常见人类白细胞抗原等位基因的患者中，别嘌醇引起的史蒂文斯-约翰逊综合征、药物性超敏反应综合征和中毒性表皮坏死松解症：多样性的成因是什么？
Dermatology. 2007;215(1):86-8. doi: 10.1159/000102045.
4
Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.别嘌醇诱发的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。
J Am Acad Dermatol. 2008 Aug;59(2):352-3. doi: 10.1016/j.jaad.2008.02.021.
5
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.在泰国人群中，HLA - B*5801与别嘌醇诱发的史蒂文斯 - 约翰逊综合征及中毒性表皮坏死松解症之间存在强关联。
Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.
6
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.在欧洲和以色列，别嘌醇是史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症最常见的病因。
J Am Acad Dermatol. 2008 Jan;58(1):25-32. doi: 10.1016/j.jaad.2007.08.036. Epub 2007 Oct 24.
7
Allopurinol-induced toxic epidermal necrolysis.
Int J Dermatol. 1984 Mar;23(2):142-4. doi: 10.1111/j.1365-4362.1984.tb05689.x.
8
Letter: Cause of adult toxic epidermal necrolysis.信件：成人中毒性表皮坏死松解症的病因。
N Engl J Med. 1975 Apr 17;292(16):870. doi: 10.1056/NEJM197504172921618.
9
Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.别嘌醇-利妥昔单抗-苯达莫司汀治疗引发的致命性史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症
J Oncol Pharm Pract. 2015 Oct;21(5):388-92. doi: 10.1177/1078155214533368. Epub 2014 Jul 7.
10
Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.疑似与史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关药物的风险评估：一项病例对照研究。
Intern Med J. 2005 Mar;35(3):188-90. doi: 10.1111/j.1445-5994.2005.00790.x.
引用本文的文献
1
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.高尿酸血症相关疾病与黄嘌呤氧化还原酶（XOR）抑制剂：综述
Med Sci Monit. 2016 Jul 17;22:2501-12. doi: 10.12659/msm.899852.
2
Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.血液系统恶性肿瘤患者的别嘌醇超敏综合征：特征与临床结局
Korean J Intern Med. 2015 Jul;30(4):521-30. doi: 10.3904/kjim.2015.30.4.521. Epub 2015 Jun 29.
3
An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.通过 HLA 分型预防别嘌醇诱导的过敏反应的有效策略。
Genet Med. 2015 Oct;17(10):807-14. doi: 10.1038/gim.2014.195. Epub 2015 Jan 29.
4
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.别嘌醇过敏反应：1950 年至 2012 年所有已发表病例的系统回顾。
Drug Saf. 2013 Oct;36(10):953-80. doi: 10.1007/s40264-013-0084-0.
5
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.HLA - B*5801等位基因作为别嘌醇引起严重皮肤不良反应的遗传标志物。
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9. doi: 10.1073/pnas.0409500102. Epub 2005 Mar 2.
6
Allopurinol, erythema multiforme, and renal insufficiency.别嘌醇、多形红斑与肾功能不全。
BMJ. 1996 Jan 20;312(7024):173-4. doi: 10.1136/bmj.312.7024.173.
7
Serum 17-beta-estradiol and testosterone levels in asymptomatic hyperuricaemic men.
Clin Rheumatol. 1994 Jun;13(2):219-23. doi: 10.1007/BF02249015.
8
Allopurinol hypersensitivity syndrome revisited.
West J Med. 1995 Apr;162(4):360-1.
9
Asymptomatic hyperuricaemia.无症状性高尿酸血症
Br Med J (Clin Res Ed). 1987 Apr 18;294(6578):987-8. doi: 10.1136/bmj.294.6578.987.
本文引用的文献
1
Management of asymptomatic hyperuricemia.
JAMA. 1981 Nov 13;246(19):2215-6.
2
Acute adverse reactions attributed to allopurinol in hospitalised patients.住院患者中归因于别嘌醇的急性不良反应。
Ann Rheum Dis. 1981 Jun;40(3):245-9. doi: 10.1136/ard.40.3.245.
3
Allopurinol-induced toxic epidermal necrolysis.
Int J Dermatol. 1984 Mar;23(2):142-4. doi: 10.1111/j.1365-4362.1984.tb05689.x.
4
Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.严重别嘌醇毒性。肾功能不全患者的描述及预防指南。
Am J Med. 1984 Jan;76(1):47-56. doi: 10.1016/0002-9343(84)90743-5.
5
Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy.别嘌醇治疗后出现中毒性表皮坏死松解症、氮质血症及死亡。
JAMA. 1970 Apr 20;212(3):478-9.
6
Toxic epidermal necrolysis associated with allopurinol administration.与别嘌醇给药相关的中毒性表皮坏死松解症。
Arch Dermatol. 1975 Aug;111(8):986-90.
7
Hyperuricaemia--to treat or not?
Drugs. 1975;9(2):141-52. doi: 10.2165/00003495-197509020-00003.
8
Asymptomatic hyperuricemia: the case for conservative management.
Ann Intern Med. 1978 May;88(5):666-70. doi: 10.7326/0003-4819-88-5-666.
9
Hyperuricemia and gout. Classification, complications and management.高尿酸血症与痛风。分类、并发症及管理
N Engl J Med. 1979 Jun 28;300(26):1459-68. doi: 10.1056/NEJM197906283002604.
10
The allopurinol hypersensitivity syndrome.
J Am Acad Dermatol. 1979 Oct;1(4):365-74. doi: 10.1016/s0190-9622(79)70031-4.
Zotero 插件